Skip to main content
SpringerLink
Log in

Transurethrale Resektion der Blase

  • Chapter
Endoskopische Urologie

  • 2949 Accesses

Zusammenfassung

Das Urothelkarzinom der Harnblase ist eine der häufigsten Tumorerkrankungen weltweit. In den westlichen Ländern der EU treten jährlich etwa 90.000 neue Erkrankungen auf, die Inzidenz liegt bei 27 bzw. 6 pro 100.000 Personen pro Jahr für Männer bzw. Frauen (Ferlay et al. 2008). Etwa 75 % der Fälle sind bei der Erstdiagnose nicht muskelinvasiv (Tumorstadien pT2–4), sondern exophytisch und auf die Mukosa beschränkt (pTa), die Lamina propria infiltrierend (pT1) oder bei geringer Differenzierung intraepithelial (Carcinoma in situ, CIS).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ferlay J, Bray F, Forman D, et al. (2008) GLOBOCAN v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 2010, International Agency for Research on Cancer: Lyon, France. http://www.iarc.fr/en/publications/eresources/cancerbases/index.php

  • Burger M, Catto JW, Dalbagni G, et al. (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol Feb;63(2):234-41. http://www.ncbi.nlm.nih.gov/pubmed/22877502

  • Steinmaus C, Ferreccio C, Acevedo J, et al. (2014) Increased lung and bladder cancer incidence in adults after in utero and early-life arsenic exposure. Cancer Epidemiol Biomarkers prev 2014 Aug;23(8):1529-38. http://www.ncbi.nlm.nih.gov/pubmed/24859871

  • Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J (2008) EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder. Eur Urol 54(2): 303–14

    Google Scholar 

  • van der Meijden APM, Sylvester R, Oosterlinck W et al. (2005) For the EAU Working Party on Non Muscle Invasive Bladder Cancer, EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ. Eur Urol 48(3): 363–371

    Google Scholar 

  • EAU guidelines on non-muscle invasive bladder cancer (2015)

    Google Scholar 

  • Goessl C, Knispel HH, Millar K, Klan R (1997) Is routine excretory urography necessary at first diagnosis of bladder cancer? J Urol 157(2): 480–481

    Google Scholar 

  • Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW, Kurth K (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49: 466–477

    Google Scholar 

  • Mungan MU, Canda AE, Tuzel E, Yorukoglu K, Kirkali Z (2005) Risk factors for mucosal prostatic urethral involvement in superficial transitional cell carcinoma of the bladder. Eur Urol 48(5): 760–763

    Google Scholar 

  • Pycha A, Lodde M, Lusuardi L, Palermo S, Signorello D, Galantini A, Mian C, Hohenfellner R (2003) Teaching transurethral resection of the bladder: still a challenge? Urology 62(1): 46–8

    Google Scholar 

  • Nieder AM, Meinbach DS, Kim SS, Soloway MS (2005) Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting. J Urol 174(6): 2307–9

    Google Scholar 

  • Skolarikos A, Chrisofos M, Ferakis N, Papatsoris A, Dellis A, Deliveliotis C (2005) Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence? J Urol 173(6): 1908–11

    Google Scholar 

  • Mydlo JH, Weinstein R, Shah S, Solliday M, Macchia RJ (1999) Long-term consequences from bladder perforation and/or violation in the presence of transitional cell carcinoma: results of a small series and a review of the literature. J Urol 161(4): 1128–32

    Google Scholar 

  • Niël-Weise BS, van den Broek PJ (2005) Antibiotic policies for short-term catheter bladder drainage in adults. Cochrane Database Syst Rev (3): CD005428

    Google Scholar 

  • Grimm MO, Steinhoff C, Simon X, Spiegelhalder P, Ackermann R, Vogeli TA (2003) Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 170: 433–437

    Google Scholar 

  • Schwaibold HE, Sivalingam S, May F, Hartung R (2006) The value of a second transurethral resection for T1 bladder cancer. BJU Int 97(6): 1199–201

    Google Scholar 

  • Brauers A, Buettner R, Jackse G (2001) Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol 165: 808–810

    Google Scholar 

  • Stenzl A, Jocham D, Jichlinski P et al. (2008) Working Group for Oncology of the German Society for Urology Photodynamic diagnostics in the urinary tract. Consensus paper of the Working Group for Oncology of the German Society for Urology. Urologe A 47(8): 982–7

    Google Scholar 

  • Ahmad I, Barnetson RJ, Krishna NS (2008) Keratinizing squamous metaplasia of the bladder: a review. Urol Int 81(3): 247–51

    Google Scholar 

  • Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA (2009) The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer. Eur Urol [Epub ahead of print] doi:10.1016/j.eururo.2009.01.002

  • Merseburger AS, Matuschek I, Kuczyk MA (2008) Bladder preserving strategies for muscle-invasive bladder cancer. Curr Opin Urol 18(5): 513–8

    Google Scholar 

  • Lodde M, Palermo S, Comploj E, Signorello D, Mian C, Lusuardi L, Longhi E, Zanon P, Mian M, Pycha A (2005) Four years experience in bladder preserving management for muscle invasive bladder cancer. Eur Urol 47(6): 773–8; discussion 778–9

    Google Scholar 

  • Jakse G, Algaba F, Malmstrom PU, Oosterlinck W (2004) A second-look TUR in T1 transitional cell carcinoma: Why? Eur Urol 45: 539–546

    Google Scholar 

  • Brausi M, Collette L, Kurth K et al. (2002) EORTC Genito-Urinary Tract Cancer Collaborative Group Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41(5): 523–531

    Google Scholar 

  • Zaak D, Karl A, Knüchel R et al. (2005) Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy. BJU Int 96: 217–22

    Google Scholar 

  • Hungerhuber E, Stepp H, Kriegmair M et al. (2007) Seven years’ experiencewith5-aminolevulinic acid in detection of transitional cell carcinomaof the bladder. Urology 69(2): 260–4

    Google Scholar 

  • Jocham D, Witjes F, Wagner S et al. (2005) Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 174(3): 862–6; discussion 866

    Google Scholar 

  • Schmidbauer J, Witjes F, Schmeller N, Donat R, Susani M, Marberger M; Hexvix PCB301/01 Study Group (2004) Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 171(1): 135–8

    Google Scholar 

  • Riedl CR, Daniltchenko D, Koenig F, Simak R, Loening SA, Pflueger H (2001) Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J Urol 165(4): 1121–3

    Google Scholar 

  • Babjuk M, Soukup V, Petrik R, Jirsa M and Dvoracek J (2005) 5-Aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. BJU Int 96: 798

    Google Scholar 

  • Daniltchenko DI, Riedl CR, Sachs MD, Koenig F, Daha KL, Pflueger H, Loening SA, Schnorr D (2005) Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol 174(6): 2129–33

    Google Scholar 

  • Denzinger S, Burger M, Walter B, Knuechel R, Roessler W, Wieland WF, Filbeck T (2007) Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology 69(4): 675–9

    Google Scholar 

  • Denzinger S, Wieland WF, Otto W, Filbeck T, Knuechel R, Burger M (2008) Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 highgrade bladder cancer? A long-term follow-up of a randomized study. BJU 101(5): 566–9

    Google Scholar 

  • Loidl W, Schmidbauer J, Susani M, Marberger M (2005) Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance? Eur Urol 47: 323–6

    Google Scholar 

  • Burger M, Zaak D, Stief CG, Filbeck T, Wieland WF, Roessler W, Denzinger S (2007) Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis. Eur Urol 52(1): 142–7

    Google Scholar 

  • Burger M, Petschl S, Volkmer BG (2008) Calculating the price of a new diagnostic or therapeutic option. Example of transurethral resection of bladder tumors using photodynamic diagnostics with hexaminolevulinic acid. Urologe A 47(9): 1239–44

    Google Scholar 

  • Jichlinski P, Guillou L, Karlsen SJ et al. (2003) Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer – a multicenter study. J Urol 170(1): 226–9

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Urologie, Caritas-Krankenhaus St. Josef, Regensburg, Deutschland

    M. Gierth

  2. Klinik für Urologie, Universität Regensburg, Regensburg, Deutschland

    M. Burger

Authors
  1. M. Gierth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Burger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitäts Klinikum Marburg, Marburg, Deutschland

    Rainer Hofmann

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland

About this chapter

Cite this chapter

Gierth, M., Burger, M. (2018). Transurethrale Resektion der Blase. In: Hofmann, R. (eds) Endoskopische Urologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53981-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-53981-1_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-53980-4

  • Online ISBN: 978-3-662-53981-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation